Ray Solano, RPh – LDN Radio Show August 2023 (LDN; low dose naltrexone)

  Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I’m your host Linda Elsegood. Today we’re joined by Ray Solano from PD Labs. He’s also a nutritionist. Could you tell us a bit of background about yourself?  I am dedicated to getting out the word on personalized medications. We […]

Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris… (News)

Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris… Cureus 24 January 2023 https://www.cureus.com/articles/132544-oral-low-dose-naltrexone-in-the-treatment-of-frontal-fibrosing-alopecia-and-lichen-planopilaris-an-uncontrolled-open-label-prospective-study#!/ Frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP) is scarring alopecias with limited evidence supporting their treatment options. We investigated the use of low-dose naltrexone (3 mg oral daily) as adjunctive therapy in the treatment of FFA […]

Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail (News)

Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail Epoch Times 04 November 2022 https://archive.ph/kwlGU#selection-347.0-347.74 Low dose naltrexone (LDN) is among the top treatments for long COVID and vaccine injuries. Doctors treating spike protein injury see it as a syndrome rather than disease, since it is precipitated by dysfunctions in many overlapping pathways. A […]